Toshio Suwa

485 total citations
42 papers, 378 citations indexed

About

Toshio Suwa is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Toshio Suwa has authored 42 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Pharmacology and 11 papers in Oncology. Recurrent topics in Toshio Suwa's work include Drug Transport and Resistance Mechanisms (10 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Analytical Chemistry and Chromatography (7 papers). Toshio Suwa is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Analytical Chemistry and Chromatography (7 papers). Toshio Suwa collaborates with scholars based in Japan. Toshio Suwa's co-authors include Yoshiro Kohno, Tetsuya Suga, Akira Tsuji, Hideo Yoshida, Hideo Yoshida, Yo Mori, Yasuro Shinohara, Atsuko Fujita, Susumu Otomo and Makoto Tanaka and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Materials Science and International Journal of Pharmaceutics.

In The Last Decade

Toshio Suwa

39 papers receiving 327 citations

Peers

Countries citing papers authored by Toshio Suwa

Since Specialization

Citations

This map shows the geographic impact of Toshio Suwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshio Suwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshio Suwa more than expected).

Fields of papers citing papers by Toshio Suwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshio Suwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshio Suwa. The network helps show where Toshio Suwa may publish in the future.

Co-authorship network of co-authors of Toshio Suwa

This figure shows the co-authorship network connecting the top 25 collaborators of Toshio Suwa. A scholar is included among the top collaborators of Toshio Suwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshio Suwa. Toshio Suwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of stepwise and simultaneous estimations of population pharmacokinetics and pharmacodynamics of TS-943 2003 ·European Journal of Drug Metabolism and Pharmacokinetics ·Atsushi Furuya, Noriko Kato, (unknown), Masayuki Akimoto, (unknown), Toshio Suwa, Mariko Sato, Hideaki Ogata	0
2	Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rats 1997 ·Biochemical Pharmacology ·Hideo Yoshida, Yoshiro Kohno, (unknown), Jun‐ichi Yamaguchi, (unknown), Toshio Suwa, (unknown)	8
3	Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in rats 1997 ·Chirality ·Hideo Yoshida, Yoshiro Kohno, (unknown), (unknown), (unknown), Toshio Suwa, (unknown)	6
4	Identification of Metabolites of KE-298, a New Antirheumatic Drug, and Its Physiological Properties in Rats. 1996 ·Biological and Pharmaceutical Bulletin ·Hideo Yoshida, Yoshiro Kohno, Hiromi Endo, Masatoshi Hasegawa, (unknown), Kazuyuki Tomisawa, Toshio Suwa	8
5	Stereoselective pharmacokinetics of [14C]-labeled KE-298, a new anti-rheumatic drug, in rats 1996 ·Chirality ·Hideo Yoshida, Yoshiro Kohno, Hiromi Endo, (unknown), Toshio Suwa	6
6	Metabolism of a nitrate ester, dihydropyridine derivative in rabbit hepatic microsomes and cytosol 1995 ·Xenobiotica ·N. Ogawa, Takehiro Hirose, (unknown), Toshio Suwa, Takaya Satoh	1
7	GSH-independent denitration of the nitrate ester of a dihydropyridine derivative in rabbit hepatic cytosol 1995 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), Toshio Suwa, Tetsuo Satoh	1
8	Release and absorption characteristics of chlorphenesin carbamate sustained-release formulations: In vitro-in vivo and in vivo dog-human correlations 1995 ·International Journal of Pharmaceutics ·Masayuki Akimoto, Atsushi Furuya, Masato Nakamura, (unknown), Kenji Yamada, Toshio Suwa, Hiroyasu Ogata	6
9	Pharmacokinetics of an Oil-in-Water Emulsion Containing Isocarbacyclin Methyl Ester, TTC-909. (3). Tissue Distribution in Rats after Single Intravenous Administration. 1995 ·Drug Metabolism and Pharmacokinetics ·Yoshiro Kohno, (unknown), Toshio Suwa, Shiro Kondo, (unknown), (unknown), (unknown), (unknown), Isao Watanabe	3
10	Entrapping Efficiency and Drug Release Profile of an Oil-in-Water (o/w) Emulsion Formulation Using a Polydimethylsiloxane-Coated Glass Bead Assay 1994 ·Pharmaceutical Research ·(unknown), Yoshiro Kohno, Toshio Suwa, Akira Tsuji	7
11	Entrapping Efficiency of an Oil-in-Water Emulsion Containing Isocarbacyclin Methyl Ester (TEI-9090) in Dog and Human Sera 1994 ·Pharmaceutical Research ·(unknown), Yoshiro Kohno, Toshio Suwa, Akira Tsuji	3
12	Metabolic fate of a new dihydropyridine calcium antagonist, CD-349, in rat and dog 1993 ·Xenobiotica ·(unknown), (unknown), (unknown), Toshio Suwa, Takaya Satoh	4
13	Simultaneous high-performance liquid chromatographic determination of lornoxicam and its 5′-hydroxy metabolite in human plasma using electrochemical detection 1993 ·Journal of Chromatography B Biomedical Sciences and Applications ·Toshio Suwa, (unknown), Yasuro Shinohara, (unknown)	22
14	Selected Ion Monitoring for the Determination of Bromovalerylurea in Human Plasma. 1992 ·Chemical and Pharmaceutical Bulletin ·(unknown), (unknown), Toshio Suwa	7
15	Determination of gallopamil in human plasma by selected ion monitoring. 1991 ·Chemical and Pharmaceutical Bulletin ·(unknown), (unknown), Toshio Suwa	1
16	Metabolic fate of loxistatin in rat 1990 ·Xenobiotica ·(unknown), M. Arai, Motoki Tamai, Chihiro Yokoo, Mikio MURATA, Toshio Suwa, Takaya Satoh	1
17	Uptake of O-Alkyl Erythromycin Derivatives in the Lung Tissue and Cells of Rats 1989 ·Journal of Pharmaceutical Sciences ·Toshio Suwa, Yoshiro Kohno, Hideo Yoshida, Shigeo Morimoto, Tetsuya Suga	3
18	Identification of Glutathione Conjugate Formed from Loxistatin in Rats 1989 ·Xenobiotica ·(unknown), M. Arai, Hidehiko Ogawa, Toshio Suwa, Takaya Satoh	5
19	Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats 1989 ·Antimicrobial Agents and Chemotherapy ·Yoshiro Kohno, Hideo Yoshida, Toshio Suwa, Tetsuya Suga	43
20	Cytoprotective Effect of SU-88, an Anti-Ulcer Agent, in the Rat 1984 ·The Japanese Journal of Pharmacology ·Toshio Suwa, (unknown), Ayako Shinozaki, (unknown), Yo Mori	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact